Selinexor in Combination With Ixazomib for the Treatment of Advanced Sarcoma

NCT03880123 · clinicaltrials.gov ↗

PHASE1

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped Study will not proceed, no participants enrolled.

Conditions

Liposarcoma
Malignant Peripheral Nerve Sheath Tumors
Alveolar Soft Part Sarcoma
Ewing Sarcoma
Sarcoma

Interventions

DRUG: Selinexor
DRUG: Ixazomib

Sponsor

Matthew Ingham

Collaborators

[object Object]
[object Object]